The Alfred E. Mann Foundation for Scientific Research (AMF) today confirmed the appointment of two new senior executives.
Los Angeles-based AMF appointed Charles Nelson as its new COO and Corey Dishmon as its chief legal officer/chief business officer.
Get the full story at our sister site, Drug Delivery Business News.
The Alfred E. Mann Foundation for Scientific Research (AMF) today announced the sale of intellectual property to Medtronic (NYSE:MDT).
As part of the transaction of IP related to implanted infusion pumps, AMF will work with Medtronic to develop the technology into a next-generation implantable insulin pump for people living with hard-to-treat type 1 diabetes in Europe.
Get the full story at our sister site, Drug Delivery Business News.